A Study to Test Feasibility and Acceptability of an Intervention Program Aiming to Reduce Prenatal Secondhand Smoke Exposure
First Breath
Feasibility and Acceptability of a Digital Intervention Program Aiming to Reduce Secondhand Smoke Exposure in Pregnancy: a Pilot Study
1 other identifier
interventional
160
1 country
1
Brief Summary
This pilot study assess the feasibility and acceptability of the "First Breath" digital behavioral intervention aiming to reduce prenatal SHS exposure. By involving both the pregnant women and partners (who smoke) of pregnant women, our intervention encourages reducing secondhand smoke exposure at home and in the car, through a gradual, capacity and self-efficacy building, structured plan. "First Breath" focus on raising knowledge about the health consequences of prenatal secondhand exposure, proposing strategies to avoid exposure, and raising motivation to implement a smoke free home and car. Our intervention also includes personal biochemical feedback to the pregnant women using urine cotinine (a marker of secondhand smoke exposure), and advice on using nicotine-replacemnt therapy within the home setting to avoid smoking.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 30, 2025
CompletedFirst Submitted
Initial submission to the registry
May 18, 2025
CompletedFirst Posted
Study publicly available on registry
June 4, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedSeptember 12, 2025
May 1, 2025
7 months
May 18, 2025
September 8, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Recruitment rate
Number of participants that sign the informed consent, divided by the total number of participants who were approached for recruitment. Recruitment rate will be calculated separately for pregnant women and expectant fathers' participants.
From day of recruitment of the first participant to day of recruitement of the last participant, assessed up to 3 months
Secondary Outcomes (13)
Overall compliance
From day of recruitment of the first participant to day of the last follow-up meeting of the last participant, assessed up to 6 months.
Intervention completion rate
From day of recruitment of the first participant to day of the last follow-up meeting of the last participant, assessed up to 6 months.
Intervention re-enter rate
From date of the first signed inform consent form until the date of the last follow-up meeting of the last participant, assessed up to 6 months.
Intervention compliance
From day of recruitment of the first participant to day of the last follow-up meeting of the last participant, assessed up to 6 months.
Performance of a cotinine baseline test (only for women)
From date of the first signed informed consent form (woman) until date of the last signed informed consent form (women), assessed up to 3 months.
- +8 more secondary outcomes
Study Arms (2)
Intervention arm: testing the "First Breath" digital intervention
EXPERIMENTALExpectant fathers receive an acess to the digital intervention "First Breath" and are asked to complete a questionnaire at baseline and after 3 months. Pregnant women receive an access to the digital intervention and are also asked to provide an urine sample (for measurement of urine cotinine concentration) and to complete a questionnaire during study visits (at Hadassah Ein Karem) at baseline, after 1 and 3 months.
Control group
NO INTERVENTIONInstead of the "First Breath" intervention, participants (both men and women) receive a link to a website that contains uploaded standard educational material from the Israel Cancer Association website. Participants will be asked to complete a questionnaire at baseline and after 1 months (only women) and 3 months follow-up, and women are asked to provide urine samples (for measurement of cotinine concentration) at baseline, after 1 and 3 months.
Interventions
The intervention focus on raising knowledge about the health consequences of prenatal secondhand smoke exposure, proposing strategies to avoid exposure at home and in the car, and raising motivation to implement a smoke-free home and car. An "exposure score" of each participant is calculated, based on his perception of secondhand smoke exposure, smoking rules within the home and strategies used to reduce exposure. Participants are guided in setting specific goals, with a detailed action plan, and receive ongoing feedback throughout follow up. In addition, for pregnant women, urine cotinine measurements at baseline, 4-weeks and 12-weeks study visit are integrated into the intervention and personalized biofeedback provided to them . Participants of the intervention arm also receive remiders (by WhatsApp) to re-use the App during all the follow-up period (3 times during the first week, 2 times/week during the 2nd, 3th and 4th weeks, and then once a week until the end of follow-up).
Eligibility Criteria
You may qualify if:
- ≤24 gestational weeks;
- at least 18 years old;
- living with a partner who smokes (at least one combustible cigarette a day); d) ability to understand Hebrew at a reasonable level;
- e) currently not smoking any tobacco or nicotine product (to clarify, women who smoked in the past are eligible).
You may not qualify if:
- women with high-risk pregnancies,
- no access to internet,
- her partner is currently involved in a smoking cessation process.
- Expectant fathers who smoke:
- male,
- at least 18 years old,
- able to understand Hebrew at a reasonable level,
- smoking at least one combustible cigarette per day,
- currently living with a pregnant spouse who does not smoke any tobacco or nicotine product and
- the spouse is ≤24 gestational weeks . Note: expectant father who are current users of other tobacco products (such as electronic cigarettes) are also eligible as long as they smoke at least one combustible cigarette a day.
- currently engaged in a smoking cessation program,
- no access to the internet.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Braun School of Public Health and Community Medicine, Hebrew University of Jerusalem
Jerusalem, Israel
Related Publications (2)
Rodnay M, Agbaria N, Neumark Y, Guri-Scherman AY, Bar Zeev Y. "What can I do? fight him?" Perceptions and Experiences in Reducing Secondhand Smoke Exposure During Pregnancy: A Qualitative Study Among Israeli Women. Nicotine Tob Res. 2025 May 22;27(6):962-969. doi: 10.1093/ntr/ntae291.
PMID: 39673392BACKGROUNDGuri-Scherman AY, Neumark Y, Rodnay M, Bar-Zeev Y. Barriers and Enablers to Implementing a Smoke-free Home and Car During Pregnancy: A Qualitative Study Among Expectant Israeli Fathers. Nicotine Tob Res. 2024 Jan 1;26(1):94-101. doi: 10.1093/ntr/ntad149.
PMID: 37565607BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yael Bar-Zeev, MD MPH PhD
Hebrew University of Jerusalem
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
May 18, 2025
First Posted
June 4, 2025
Study Start
March 30, 2025
Primary Completion
October 30, 2025
Study Completion
December 1, 2025
Last Updated
September 12, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- Immediately following publication, no end date
- Access Criteria
- Researchers who provide a methodologically sound proposal, proposals should be directed to Yael.Bar-Zeev@mail.huji.ac.il. To gain access, researchers will need to sign a data access agreement
Individual participant data that underlie the results after deidentification